Insights into Function, Catalytic Mechanism, and Fold Evolution of Selenoprotein Methionine Sulfoxide Reductase B1 through Structural Analysis, Journal of Biological Chemistry, vol.1703, issue.43, 2010. ,
DOI : 10.1074/jbc.M407464200
Cell Cycle Control by the CDC25 Phosphatases, Anti-Cancer Agents in Medicinal Chemistry, vol.8, issue.8, pp.818-824, 2008. ,
DOI : 10.2174/187152008786847756
Focus on mammalian thioredoxin reductases ??? Important selenoproteins with versatile functions, Biochimica et Biophysica Acta (BBA) - General Subjects, vol.1790, issue.6, pp.495-526, 2009. ,
DOI : 10.1016/j.bbagen.2009.01.014
1-Chloro-2,4-dinitrobenzene Is an Irreversible Inhibitor of Human Thioredoxin Reductase, Journal of Biological Chemistry, vol.38, issue.8, pp.3479-3482, 1995. ,
DOI : 10.1016/0006-291X(90)91961-Q
The thioredoxin system in cancer, Seminars in Cancer Biology, vol.16, issue.6, pp.420-426, 2006. ,
DOI : 10.1016/j.semcancer.2006.10.009
Analysis of the inhibition of mammalian thioredoxin, thioredoxin reductase, and glutaredoxin by cisdiamminedichloroplatinum (II) and its major metabolite, the glutathione-platinum complex, Free Radic Biol Med, issue.10, pp.31-1170, 2001. ,
Cyclin E Deregulation Impairs Mitotic Progression through Premature Activation of Cdc25C, Cancer Research, vol.70, issue.12, pp.5085-5095, 2010. ,
DOI : 10.1158/0008-5472.CAN-09-4095
The antitumor thioredoxin-1 inhibitor PX-12 (1-methylpropyl 2-imidazolyl disulfide) decreases thioredoxin-1 and VEGF levels in cancer patient plasma, Journal of Laboratory and Clinical Medicine, vol.147, issue.2, pp.83-90, 2006. ,
DOI : 10.1016/j.lab.2005.09.001
Screening for antimitotic compounds using the cdc25 tyrosine phosphatase, an activator of the mitosis-inducing p34cdc2/cyclin Bcdc13 protein kinase, Anticancer Res, vol.12, issue.3, pp.873-880, 1992. ,
H2O2 induces a transient multi-phase cell cycle arrest in mouse fibroblasts through modulating cyclin D and p21Cip1 expression, J Biol Chem, vol.277, issue.16, pp.13761-13770, 2002. ,
The oligomeric conformation of peroxiredoxins links redox state to function, FEBS Letters, vol.104, issue.12, pp.1809-1816, 2009. ,
DOI : 10.1016/S1369-7021(05)71078-6
Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines, Oncogene, vol.5, issue.6, pp.893-899, 1990. ,
Superoxide dismutase: Improved assays and an assay applicable to acrylamide gels, Analytical Biochemistry, vol.44, issue.1, pp.276-287, 1971. ,
DOI : 10.1016/0003-2697(71)90370-8
The thioredoxin reductase/thioredoxin system: Novel redox targets for cancer therapy, Cancer Biology & Therapy, vol.4, issue.1, pp.6-13, 2005. ,
DOI : 10.4161/cbt.4.1.1434
A rapid alkaline extraction procedure for screening recombinant plasmid DNA, Nucleic Acids Research, vol.7, issue.6, pp.1513-1523, 1979. ,
DOI : 10.1093/nar/7.6.1513
Recent clinical trials using cisplatin, carboplatin and their combination chemotherapy drugs (Review), Oncology Reports, vol.11, issue.3, pp.559-595, 2004. ,
DOI : 10.3892/or.11.3.559
The when and wheres of CDC25 phosphatases, Current Opinion in Cell Biology, vol.18, issue.2, pp.185-191, 2006. ,
DOI : 10.1016/j.ceb.2006.02.003
URL : https://hal.archives-ouvertes.fr/hal-00317392
CDC25 phosphatases in cancer cells: key players? Good targets?, Nature Reviews Cancer, vol.20, issue.7, pp.495-507, 2007. ,
DOI : 10.1158/0008-5472.CAN-05-1054
URL : https://hal.archives-ouvertes.fr/hal-00317350
Elucidation of Thioredoxin as a Molecular Target for Antitumor Quinols, Cancer Research, vol.65, issue.9, pp.3911-3919, 2005. ,
DOI : 10.1158/0008-5472.CAN-04-4141
Redox regulation of Cdc25B by cell active quinolinediones, Molecular Pharmacology, vol.68, issue.6, pp.1810-1820, 2005. ,
DOI : 10.1124/mol.105.016360
Mitochondrial respiratory chain involvement in peroxiredoxin 3 oxidation by phenethyl isothiocyanate and auranofin, FEBS Letters, vol.47, issue.6, pp.1257-1262, 2010. ,
DOI : 10.1016/j.freeradbiomed.2009.05.027
Role of thioredoxin reductase 1 and thioredoxin interacting protein in prognosis of breast cancer, Breast Cancer Res, vol.12, issue.3, p.44, 2010. ,
Breast Tumor Cell Lines From Pleural Effusions
2, JNCI: Journal of the National Cancer Institute, vol.53, issue.3, pp.661-674, 1974. ,
DOI : 10.1093/jnci/53.3.661
Role of the Cdc25A phosphatase in human breast cancer, Journal of Clinical Investigation, vol.106, issue.6, pp.753-761, 2000. ,
DOI : 10.1172/JCI9174
Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity, Prdx1 inhibits tumorigenesis via regulating PTEN/AKT activity, pp.1505-1517, 2009. ,
DOI : 10.1021/bi00087a012
URL : http://emboj.embopress.org/content/embojnl/28/10/1505.full.pdf
Glutathionylation of human thioredoxin: A possible crosstalk between the glutathione and thioredoxin systems, Proceedings of the National Academy of Sciences, vol.17, issue.9, pp.99-9745, 2002. ,
DOI : 10.1093/emboj/17.9.2596
Le dimethylsulfoxyde (DMSO): principale propriétés et usage autorisés, pp.207-220, 2011. ,
Interactions of Nitroaromatic Compounds with the Mammalian Selenoprotein Thioredoxin Reductase and the Relation to Induction of Apoptosis in Human Cancer Cells, Journal of Biological Chemistry, vol.18, issue.9, pp.5593-5603, 2006. ,
DOI : 10.1128/AEM.68.4.1690-1696.2002
Biochemical Mechanisms of Cisplatin Cytotoxicity, Anti-Cancer Agents in Medicinal Chemistry, vol.7, issue.1, pp.3-18, 2007. ,
DOI : 10.2174/187152007779314044
Overexpression of peroxiredoxin I and thioredoxin1 in human breast carcinoma, Journal of Experimental & Clinical Cancer Research, vol.28, issue.1, p.93, 2009. ,
DOI : 10.1186/1756-9966-28-93
Redox Regulation of SH2-Domain-Containing Protein Tyrosine Phosphatases by Two Backdoor Cysteines, Biochemistry, vol.48, issue.6, pp.1399-1409, 2009. ,
DOI : 10.1021/bi801973z
Nuclear thioredoxin-1 is required to suppress cisplatin-mediated apoptosis of MCF-7 cells, Biochemical and Biophysical Research Communications, vol.361, issue.2, pp.362-366, 2007. ,
DOI : 10.1016/j.bbrc.2007.07.033
Survival or Death: The Redox Paradox, Antioxidants & Redox Signaling, vol.11, issue.11, pp.2651-2654, 2009. ,
DOI : 10.1089/ars.2009.2770
Protein Tyrosine Phosphorylation and Reversible Oxidation: Two Cross-Talking Posttranslation Modifications, Antioxidants & Redox Signaling, vol.9, issue.1, pp.1-24, 2007. ,
DOI : 10.1089/ars.2007.9.1
Redox regulation of protein tyrosine phosphatases during receptor tyrosine kinase signal transduction, Trends in Biochemical Sciences, vol.28, issue.9, pp.509-514, 2003. ,
DOI : 10.1016/S0968-0004(03)00174-9
Reactive oxygen species as essential mediators of cell adhesion: the oxidative inhibition of a FAK tyrosine phosphatase is required for cell adhesion, J Cell Biol, vol.161, issue.5, pp.933-944, 2003. ,
-mediated cell signaling, FEBS Letters, vol.425, issue.1-3, pp.1-3, 2004. ,
DOI : 10.1038/nature02075
Cell Cycle Arrest Induced by Hydrogen Peroxide Is Associated with Modulation of Oxidative Stress Related Genes in Breast Cancer Cells, Experimental Biology and Medicine, vol.234, issue.9, pp.1086-1094, 2009. ,
DOI : 10.1074/jbc.M111123200
Structure, Function, and Mechanism of Thioredoxin Proteins, Antioxidants & Redox Signaling, vol.13, issue.8, 2010. ,
DOI : 10.1089/ars.2010.3114
The thioredoxin reductase inhibitor auranofin triggers apoptosis through a Bax/Bak-dependent process that involves peroxiredoxin 3 oxidation, Biochemical Pharmacology, vol.76, issue.9, pp.1097-1109, 2008. ,
DOI : 10.1016/j.bcp.2008.08.021
Mitochondrial peroxiredoxin involvement in antioxidant defence and redox signalling, Biochemical Journal, vol.839, issue.2, pp.313-325, 2010. ,
DOI : 10.1074/jbc.M801047200
Protein Disulfide Bond Formation in the Cytoplasm during Oxidative Stress, Journal of Biological Chemistry, vol.267, issue.21, pp.21749-21758, 2004. ,
DOI : 10.1074/jbc.M313721200
Protein S-glutathionylation: a regulatory device from bacteria to humans, Trends in Biochemical Sciences, vol.34, issue.2, pp.85-96, 2009. ,
DOI : 10.1016/j.tibs.2008.11.002
and Reactivation by Thioredoxin, Journal of Biological Chemistry, vol.50, issue.18, pp.12373-12386, 2008. ,
DOI : 10.1002/prot.20825
Arsenic Trioxide: New Clinical Experience With an Old Medication in Hematologic Malignancies, Journal of Clinical Oncology, vol.23, issue.10, pp.2396-2410, 2005. ,
DOI : 10.1200/JCO.2005.10.217
Regulation of the high basal expression of the manganese superoxide dismutase gene in aggressive breast cancer cells, Free Radical Biology and Medicine, vol.50, issue.12, pp.1771-1779, 2011. ,
DOI : 10.1016/j.freeradbiomed.2011.03.013
URL : https://hal.archives-ouvertes.fr/hal-00747766
High levels of thioredoxin reductase 1 modulate drug-specific cytotoxic efficacy, Free Radical Biology and Medicine, vol.47, issue.11, pp.1661-1671, 2009. ,
DOI : 10.1016/j.freeradbiomed.2009.09.016
Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes, Free Radical Biology and Medicine, vol.11, issue.1, pp.81-128, 1991. ,
DOI : 10.1016/0891-5849(91)90192-6
Motexafin gadolinium generates reactive oxygen species and induces apoptosis in sensitive and highly resistant multiple myeloma cells, Blood, vol.105, issue.3, pp.1265-1273, 2005. ,
DOI : 10.1182/blood-2004-03-0964
Thioredoxin Reductase Is Irreversibly Modified by Curcumin, Journal of Biological Chemistry, vol.11, issue.26, pp.25284-25290, 2005. ,
DOI : 10.1016/j.drup.2004.01.004
URL : http://www.jbc.org/content/280/26/25284.full.pdf
Thioredoxin alters the matrix metalloproteinase/tissue inhibitors of metalloproteinase balance and stimulates human SK-N-SH neuroblastoma cell invasion, European Journal of Biochemistry, vol.257, issue.112, pp.405-413, 2001. ,
DOI : 10.1006/bbrc.1999.0408
Signaling Functions of Reactive Oxygen Species, Biochemistry, vol.49, issue.5, pp.835-842, 2010. ,
DOI : 10.1021/bi9020378
Scavenging and Signaling, Antioxidants & Redox Signaling, vol.10, issue.9, pp.1565-1576, 2008. ,
DOI : 10.1089/ars.2008.2049
Thioredoxin and protein kinases in redox signaling, Seminars in Cancer Biology, vol.16, issue.6, pp.427-435, 2006. ,
DOI : 10.1016/j.semcancer.2006.09.003
Thiolation of Protein-bound Carcinogenic Aldehyde, Journal of Biological Chemistry, vol.964, issue.7, pp.27919-27926, 2002. ,
DOI : 10.1016/0003-2697(76)90326-2
Hyperphosphorylation of the N-terminal Domain of Cdc25 Regulates Activity toward Cyclin B1/Cdc2 But Not Cyclin A/Cdk2, Journal of Biological Chemistry, vol.101, issue.45, pp.28607-28614, 1997. ,
DOI : 10.1038/sj.onc.1201254
Inhibitory effects of thioredoxin reductase antisense RNA on the growth of human hepatocellular carcinoma cells, Journal of Cellular Biochemistry, vol.97, issue.3, pp.653-664, 2005. ,
DOI : 10.1101/SQB.1994.059.01.035
Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase, Biochem Pharmacol, vol.79, issue.2, pp.90-101, 2010. ,
URL : https://hal.archives-ouvertes.fr/hal-00535818
Antisense phosphorothioate oligonucleotides specifically down-regulate cdc25B causing S-phase delay and persistent antiproliferative effects, International Journal of Cancer, vol.271, issue.5, pp.720-728, 1998. ,
DOI : 10.1074/jbc.271.9.5118
that requires GSH/Grx for its reduction, FEBS Letters, vol.278, issue.3, pp.443-448, 2003. ,
DOI : 10.1074/jbc.M303477200
Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals?, Nature Reviews Molecular Cell Biology, vol.25, issue.9, pp.722-728, 2007. ,
DOI : 10.1093/gerona/61.1.36
Reactive Aldehyde Modification of Thioredoxin-1 Activates Early Steps of Inflammation and Cell Adhesion, The American Journal of Pathology, vol.171, issue.5, pp.1670-1681, 2007. ,
DOI : 10.2353/ajpath.2007.070218
Reactive species: A cell damaging rout assisting to chemical carcinogens, Cancer Letters, vol.266, issue.1, pp.73-83, 2008. ,
DOI : 10.1016/j.canlet.2008.02.035
Hydrogen Peroxide as a Cell-Survival Signaling Molecule, Antioxidants & Redox Signaling, vol.11, issue.11, pp.2655-2671, 2009. ,
DOI : 10.1089/ars.2009.2728
Human Placenta Thioredoxin Reductase, Journal of Biological Chemistry, vol.332, issue.32, pp.20096-20101, 1998. ,
DOI : 10.1042/bj3320591
The thioredoxin system?From science to clinic, Medicinal Research Reviews, vol.278, issue.1, pp.40-89, 2004. ,
DOI : 10.1074/jbc.M303762200
Glutathione S-transferases. The first enzymatic step in mercapturic acid formation, J Biol Chem, vol.249, issue.22, pp.7130-7139, 1974. ,
The Hallmarks of Cancer, Cell, vol.100, issue.1, pp.57-70, 2000. ,
DOI : 10.1016/S0092-8674(00)81683-9
Motexafin Gadolinium, a Tumor-selective Drug Targeting Thioredoxin Reductase and Ribonucleotide Reductase, Journal of Biological Chemistry, vol.296, issue.16, pp.10691-10697, 2006. ,
DOI : 10.1093/emboj/17.9.2596
Regulation of Redox Signaling by Selenoproteins, Biological Trace Element Research, vol.66, issue.Spec No 1, pp.235-251, 2010. ,
DOI : 10.1016/j.bbagen.2009.03.002
p53-dependent inhibition of TrxR1 contributes to the tumor-specific induction of apoptosis by RITA, Cell Cycle, vol.8, issue.21, pp.3576-3583, 2009. ,
DOI : 10.4161/cc.8.21.9977
Intrinsic oxidative stress in cancer cells: a biochemical basis for therapeutic selectivity, Cancer Chemotherapy and Pharmacology, vol.53, issue.3, pp.209-219, 2004. ,
DOI : 10.1007/s00280-003-0726-5
Bovine thioredoxin system. Purification of thioredoxin reductase from calf liver and thymus and studies of its function in disulfide reduction, J Biol Chem, vol.252, issue.13, pp.4600-4606, 1977. ,
Thioredoxin and thioredoxin reductase: Current research with special reference to human disease, Biochemical and Biophysical Research Communications, vol.396, issue.1, pp.120-124, 2010. ,
DOI : 10.1016/j.bbrc.2010.03.083
Casein kinase 1 functions as both penultimate and ultimate kinase in regulating Cdc25A destruction, Oncogene, vol.6, issue.23, pp.3324-3334, 2010. ,
DOI : 10.1128/MCB.19.9.6379
Relationships between cell density, glutathione and proliferation of A549 human lung adenocarcinoma cells treated with acrolein, Toxicology, vol.122, issue.1-2, pp.111-122, 1997. ,
DOI : 10.1016/S0300-483X(97)00086-3
The Extracellular Signal-regulated Kinase-Mitogen-activated Protein Kinase Pathway Phosphorylates and Targets Cdc25A for SCF??-TrCP-dependent Degradation for Cell Cycle Arrest, Molecular Biology of the Cell, vol.20, issue.8, pp.2186-2195, 2009. ,
DOI : 10.1091/mbc.E09-01-0008
Expression of cdc25A and cdc25B phosphatase in breast carcinoma, Breast Cancer, vol.9, issue.3, pp.295-300, 2004. ,
DOI : 10.1038/bjc.1997.261
Stable Compounds of Cigarette Smoke Induce Endothelial Superoxide Anion Production via NADPH Oxidase Activation, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.24, issue.6, pp.1031-1036, 2004. ,
DOI : 10.1161/01.ATV.0000127083.88549.58
Novel Thioredoxin Inhibitors Paradoxically Increase Hypoxia-Inducible Factor-?? Expression but Decrease Functional Transcriptional Activity, DNA Binding, and Degradation, Clinical Cancer Research, vol.12, issue.18, pp.5384-5394, 2006. ,
DOI : 10.1158/1078-0432.CCR-05-2380
Identification of N-Terminally Truncated Stable Nuclear Isoforms of CDC25B That Are Specifically Involved in G2/M Checkpoint Recovery, Cancer Research, vol.71, issue.5, pp.1968-1977, 2011. ,
DOI : 10.1158/0008-5472.CAN-10-2453
Thioredoxin restores nitric oxide-induced inhibition of protein kinase C activity in lung endothelial cells, Molecular and Cellular Biochemistry, vol.254, issue.1/2, pp.47-54, 2003. ,
DOI : 10.1023/A:1027380828645
Thioredoxin and thioredoxin-binding protein-2 in cancer and metabolic syndrome, Free Radical Biology and Medicine, vol.43, issue.6, pp.861-868, 2007. ,
DOI : 10.1016/j.freeradbiomed.2007.05.032
2-Cys peroxiredoxin function in intracellular signal transduction: therapeutic implications, Trends in Molecular Medicine, vol.11, issue.12, pp.571-578, 2005. ,
DOI : 10.1016/j.molmed.2005.10.006
GSK-3?? Targets Cdc25A for Ubiquitin-Mediated Proteolysis, and GSK-3?? Inactivation Correlates with Cdc25A Overproduction in Human Cancers, Cancer Cell, vol.13, issue.1, pp.36-47, 2008. ,
DOI : 10.1016/j.ccr.2007.12.002
Cdc25: mechanisms of checkpoint inhibition and recovery, Trends in Cell Biology, vol.16, issue.6, pp.285-292, 2006. ,
DOI : 10.1016/j.tcb.2006.04.002
Role of manganese superoxide dismutase on growth and invasive properties of human estrogen-independent breast cancer cells, Breast Cancer Research and Treatment, vol.8, issue.2, pp.203-215, 2008. ,
DOI : 10.1128/MCB.17.7.3629
Clinical pharmacology of gold, Inflammopharmacology, vol.16, issue.3, pp.112-125, 2008. ,
DOI : 10.1007/s10787-007-0021-x
The Molecular Effects of Acrolein, Toxicological Sciences, vol.57, issue.1, pp.6-15, 2000. ,
DOI : 10.1093/toxsci/57.1.6
Enhanced expression of mitochondrial superoxide dismutase leads to prolonged in vivo cell cycle progression and up-regulation of mitochondrial thioredoxin, Free Radical Biology and Medicine, vol.48, issue.11, pp.1501-1512, 2010. ,
DOI : 10.1016/j.freeradbiomed.2010.02.028
Reversible Modulation of Cell Cycle Kinetics in NIH/3T3 Mouse Fibroblasts by Inducible Overexpression of Mitochondrial Manganese Superoxide Dismutase, Antioxidants & Redox Signaling, vol.6, issue.3, pp.489-500, 2004. ,
DOI : 10.1089/152308604773934251
High Thioredoxin Expression Is Associated with Resistance to Docetaxel in Primary Breast Cancer, Clinical Cancer Research, vol.11, issue.23, pp.8425-8430, 2005. ,
DOI : 10.1158/1078-0432.CCR-05-0449
Increased expression of Nrf2/ARE-dependent anti-oxidant proteins in tamoxifen-resistant breast cancer cells, Free Radical Biology and Medicine, vol.45, issue.4, pp.537-546, 2008. ,
DOI : 10.1016/j.freeradbiomed.2008.05.011
Mechanisms of inhibition of the thioredoxin growth factor system by antitumor 2-imidazolyl disulfides, Biochem Pharmacol, vol.55, issue.7, pp.987-994, 1998. ,
Parallel syntheses of disulfide inhibitors of the thioredoxin redox system as potential antitumor agents, Anticancer Drug Des, vol.14, issue.5, pp.421-432, 1999. ,
In Vivo Roles of CDC25 Phosphatases: Biological Insight into the Anti-Cancer Therapeutic Targets, Anti-Cancer Agents in Medicinal Chemistry, vol.8, issue.8, pp.832-836, 2008. ,
DOI : 10.2174/187152008786847693
Cdc25 Phosphatases and Cancer, Chemistry & Biology, vol.11, issue.8, pp.1043-1051, 2004. ,
DOI : 10.1016/j.chembiol.2004.07.007
Oxidative Stress Is Inherent in Prostate Cancer Cells and Is Required for Aggressive Phenotype, Cancer Research, vol.68, issue.6, pp.1777-1785, 2008. ,
DOI : 10.1158/0008-5472.CAN-07-5259
Cell line-directed screening assay for inhibitors of thioredoxin reductase signaling as potential anti-cancer drugs, Anticancer Drug Des, vol.12, issue.8, pp.659-670, 1997. ,
Flow cytometry study of cell cycle, apoptosis and drug resistance in acute leukemia, Hematology and Cell Therapy, vol.38, issue.6, pp.495-504, 1996. ,
DOI : 10.1007/s00282-996-0495-9
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4, Nature, vol.244, issue.5259, pp.680-685, 1970. ,
DOI : 10.1101/SQB.1963.028.01.053
Reactive Oxygen Species Production by Mitochondria, Methods Mol Biol, vol.554, pp.165-181, 2009. ,
DOI : 10.1007/978-1-59745-521-3_11
FoxM1: At the crossroads of ageing and cancer, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol.1775, issue.1, pp.92-102, 2007. ,
DOI : 10.1016/j.bbcan.2006.08.006
CDC25A and B Dual-Specificity Phosphatase Inhibitors: Potential Agents for Cancer Therapy, Current Medicinal Chemistry, vol.16, issue.15, pp.1831-1849, 2009. ,
DOI : 10.2174/092986709788186084
Evaluation of the probe 2',7'-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress, Chemical Research in Toxicology, vol.5, issue.2, pp.227-231, 1992. ,
DOI : 10.1021/tx00026a012
Functions and evolution of selenoprotein methionine sulfoxide reductases, Biochimica et Biophysica Acta (BBA) - General Subjects, vol.1790, issue.11, pp.1790-1471, 2009. ,
DOI : 10.1016/j.bbagen.2009.04.014
Reversible Inactivation of Protein-tyrosine Phosphatase 1B in A431 Cells Stimulated with Epidermal Growth Factor, Journal of Biological Chemistry, vol.11, issue.25, pp.15366-15372, 1998. ,
DOI : 10.1126/science.279.5347.88
Enhancement of Metabolic Oxidative Stress-Induced Cytotoxicity by the Thioredoxin Inhibitor 1-Methylpropyl 2-Imidazolyl Disulfide Is Mediated through the ASK1-SEK1-JNK1 Pathway, Molecular Pharmacology, vol.62, issue.6, pp.1409-1417, 2002. ,
DOI : 10.1124/mol.62.6.1409
Analysis of Glutathione and Glutathione Disulfide in Whole Cells and Mitochondria by Postcolumn Derivatization High-Performance Liquid Chromatography with ortho-Phthalaldehyde, Analytical Biochemistry, vol.274, issue.1, pp.125-130, 1999. ,
DOI : 10.1006/abio.1999.4258
Redox regulation of PI 3-kinase signalling via inactivation of PTEN, The EMBO Journal, vol.22, issue.20, pp.5501-5510, 2003. ,
DOI : 10.1093/emboj/cdg513
The role of oxidative stress in acrolein-induced DNA damage in HepG2 cells, Free Radical Research, vol.103, issue.4, pp.354-361, 2008. ,
DOI : 10.1073/pnas.0607031103
Modulation of antioxidant enzymes, reactive oxygen species, and glutathione levels in manganese superoxide dismutase-overexpressing NIH/3T3 fibroblasts during the cell cycle, Journal of Cellular Physiology, vol.14, issue.1, pp.148-160, 1998. ,
DOI : 10.1038/sj.onc.1200852
The thioredoxinthioredoxin reductase system: over-expression in human cancer, Anticancer Res, vol.23, issue.3B, pp.2425-2433, 2003. ,
Cdc25B cooperates with Cdc25A to induce mitosis but has a unique role in activating cyclin B1???Cdk1 at the centrosome, The Journal of Cell Biology, vol.269, issue.1, pp.35-45, 2005. ,
DOI : 10.1074/jbc.M305178200
ROS and p53: A versatile partnership, Free Radical Biology and Medicine, vol.44, issue.8, pp.1529-1535, 2008. ,
DOI : 10.1016/j.freeradbiomed.2008.01.011
Distinct modes of deregulation of the proto-oncogenic Cdc25A phosphatase in human breast cancer cell lines, Oncogene, vol.22, issue.50, pp.8063-8071, 2003. ,
DOI : 10.1038/35044005
Protein measurement with the Folin phenol reagent, J Biol Chem, vol.193, issue.1, pp.265-275, 1951. ,
Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide, Proceedings of the National Academy of Sciences, vol.252, issue.5, pp.12288-12293, 2007. ,
DOI : 10.1006/meth.1995.1025
Inhibition of Mammalian Thioredoxin Reductase by Some Flavonoids: Implications for Myricetin and Quercetin Anticancer Activity, Cancer Research, vol.66, issue.8, pp.4410-4418, 2006. ,
DOI : 10.1158/0008-5472.CAN-05-3310
The chemistry of the metabolites of cyclophosphamide, Curr Pharm Des, vol.5, issue.8, pp.627-643, 1999. ,
Motexafin gadolinium: A novel redox active drug for cancer therapy, Seminars in Cancer Biology, vol.16, issue.6, pp.466-476, 2006. ,
DOI : 10.1016/j.semcancer.2006.09.002
Exploring the biochemical mechanisms of cytotoxic gold compounds: a proteomic study, JBIC Journal of Biological Inorganic Chemistry, vol.49, issue.4, pp.573-582, 2010. ,
DOI : 10.1038/emm.2002.38
??H2AX: a sensitive molecular marker of DNA damage and repair, Leukemia, vol.678, issue.4, pp.679-686, 2010. ,
DOI : 10.1002/cyto.a.20426
Regulation of G2/M events by Cdc25A through phosphorylation-dependent modulation of its stability, The EMBO Journal, vol.21, issue.21, pp.5911-5920, 2002. ,
DOI : 10.1093/emboj/cdf567
Cell cycle, CDKs and cancer: a changing paradigm, Nature Reviews Cancer, vol.436, issue.3, pp.153-166, 2009. ,
DOI : 10.1101/gad.8.1.9
Thioredoxin in cancer???Role of histone deacetylase inhibitors, Seminars in Cancer Biology, vol.16, issue.6, pp.436-443, 2006. ,
DOI : 10.1016/j.semcancer.2006.09.005
Inhibition of thioredoxin reductase by auranofin induces apoptosis in cisplatin-resistant human ovarian cancer cells, Free Radical Biology and Medicine, vol.42, issue.6, pp.872-881, 2007. ,
DOI : 10.1016/j.freeradbiomed.2006.12.021
The thioredoxin system in retroviral infection and apoptosis, Cell Death & Differentiation, vol.3, issue.S1, pp.991-998, 2005. ,
DOI : 10.1128/JVI.77.5.3319-3325.2003
The thioredoxin system in retroviral infection and apoptosis, Cell Death & Differentiation, vol.3, issue.S1, pp.991-998, 2005. ,
DOI : 10.1128/JVI.77.5.3319-3325.2003
Thiordoxin regulates the DNA binding activity of NF-??B by reduction of a disulphid bond involving cysteine 62, Nucleic Acids Research, vol.20, issue.15, pp.3821-3830, 1992. ,
DOI : 10.1093/nar/20.15.3821
Regulation of Insulin Signaling through Reversible Oxidation of the Protein-tyrosine Phosphatases TC45 and PTP1B, Journal of Biological Chemistry, vol.114, issue.36, pp.37716-37725, 2004. ,
DOI : 10.1038/sj.onc.1201279
Reversible Oxidation and Inactivation of Protein Tyrosine Phosphatases In Vivo, Molecular Cell, vol.9, issue.2, pp.387-399, 2002. ,
DOI : 10.1016/S1097-2765(02)00445-8
Gold complexes as prospective metal-based anticancer drugs, Histol Histopathol, vol.23, issue.1, pp.101-108, 2008. ,
Molecular Targets of Arsenic Trioxide in Malignant Cells, The Oncologist, vol.7, issue.90001, 2002. ,
DOI : 10.1634/theoncologist.7-suppl_1-14
Mechanisms of action of arsenic trioxide, Cancer Res, vol.62, issue.14, pp.3893-3903, 2002. ,
Thioredoxin is required for S-nitrosation of procaspase-3 and the inhibition of apoptosis in Jurkat cells, Proceedings of the National Academy of Sciences, vol.169, issue.9, pp.11609-11614, 2007. ,
DOI : 10.4049/jimmunol.169.9.4805
A study of the relative importance of the peroxiredoxin-, catalase-, and glutathione-dependent systems in neural peroxide metabolism, Free Radical Biology and Medicine, vol.51, issue.1, pp.69-77, 2011. ,
DOI : 10.1016/j.freeradbiomed.2011.03.017
The thioredoxin system: a key target in tumour and endothelial cells, The British Journal of Radiology, vol.81, issue.special_issue_1, pp.57-68, 2008. ,
DOI : 10.1016/j.febslet.2006.03.029
Cytotoxic and antiangiogenic activity of AW464 (NSC 706704), a novel thioredoxin inhibitor: an in vitro study, British Journal of Cancer, vol.279, issue.112, pp.350-358, 2005. ,
DOI : 10.1074/jbc.M310164200
Thioredoxin reductase, Biochemical Journal, vol.346, issue.1, pp.1-8, 2000. ,
DOI : 10.1042/bj3460001
The effects of acrolein on peroxiredoxins, thioredoxins, and thioredoxin reductase in human bronchial epithelial cells, Toxicology, vol.257, issue.1-2, pp.95-104, 2009. ,
DOI : 10.1016/j.tox.2008.12.013
Hexavalent chromium causes the oxidation of thioredoxin in human bronchial epithelial cells, Toxicology, vol.246, issue.2-3, pp.222-233, 2008. ,
DOI : 10.1016/j.tox.2008.01.017
The effects of hexavalent chromium on thioredoxin reductase and peroxiredoxins in human bronchial epithelial cells, Free Radical Biology and Medicine, vol.47, issue.10, pp.1477-1485, 2009. ,
DOI : 10.1016/j.freeradbiomed.2009.08.015
Disulfide Bond-mediated Multimerization of Ask1 and Its Reduction by Thioredoxin-1 Regulate H2O2-induced c-Jun NH2-terminal Kinase Activation and Apoptosis, Molecular Biology of the Cell, vol.18, issue.10, pp.3903-3913, 2007. ,
DOI : 10.1091/mbc.E07-05-0491
Thioredoxin 1 delivery as new therapeutics, Advanced Drug Delivery Reviews, vol.61, issue.4, pp.303-309, 2009. ,
DOI : 10.1016/j.addr.2009.01.003
Redox control of catalytic activities of membrane-associated protein tyrosine kinases, Archives of Biochemistry and Biophysics, vol.434, issue.1, pp.3-10, 2005. ,
DOI : 10.1016/j.abb.2004.06.016
Overexpression of enzymatically active human cytosolic and mitochondrial thioredoxin reductase in HEK-293 cells. Effect on cell growth and differentiation, J Biol Chem, vol.279, issue.52, pp.54510-54517, 2004. ,
Superoxide dismutase and thioredoxin restore defective p34cdc2 kinase activation in mouse two-cell block, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol.1176, issue.1-2, pp.90-94, 1993. ,
DOI : 10.1016/0167-4889(93)90182-O
Peroxiredoxin 1 and its role in cell signaling, Cell Cycle, vol.8, issue.24, pp.4072-4078, 2009. ,
DOI : 10.4161/cc.8.24.10242
Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies, Medicinal Research Reviews, vol.4, issue.3, pp.550-580, 2010. ,
DOI : 10.1039/a702757e
Reactive oxygen species, antioxidants, and the mammalian thioredoxin system1 1This review is based on the licentiate thesis ???Thioredoxin reductase???interactions with the redox active compounds 1-chloro-2,4-dinitrobenzene and lipoic acid??? by Jonas Nordberg, 2001, Karolinska Institute, Stockholm, ISBN 91-631-1064-4., Free Radical Biology and Medicine, vol.31, issue.11, pp.1287-1312, 2001. ,
DOI : 10.1016/S0891-5849(01)00724-9
Mammalian Thioredoxin Reductase Is Irreversibly Inhibited by Dinitrohalobenzenes by Alkylation of Both the Redox Active Selenocysteine and Its Neighboring Cysteine Residue, Journal of Biological Chemistry, vol.28, issue.18, pp.10835-10842, 1998. ,
DOI : 10.3109/10715769209079515
Signaling Components of Redox Active Endosomes: The Redoxosomes, Antioxidants & Redox Signaling, vol.11, issue.6, pp.1313-1333, 2009. ,
DOI : 10.1089/ars.2008.2363
Mechanism of the tumor suppressive effect of MnSOD overexpression, Biomedicine & Pharmacotherapy, vol.59, issue.4, pp.143-148, 2005. ,
DOI : 10.1016/j.biopha.2005.03.006
Homeostatic functions of the p53 tumor suppressor: Regulation of energy metabolism and antioxidant defense, Seminars in Cancer Biology, vol.19, issue.1, pp.32-41, 2009. ,
DOI : 10.1016/j.semcancer.2008.11.005
Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1), Toxicology in Vitro, vol.20, issue.6, pp.882-890, 2006. ,
DOI : 10.1016/j.tiv.2006.01.012
Oxidative Stress, Disease-a-Month, vol.52, issue.5, pp.183-198, 2006. ,
DOI : 10.1016/j.disamonth.2006.05.003
Inhibition of Cell Growth by Overexpression of Manganese Superoxide Dismutase (MnSOD) in Human Pancreatic Carcinoma, Free Radical Research, vol.2, issue.6, pp.1223-1233, 2004. ,
DOI : 10.1074/jbc.M307677200
Discovery of Novel Cdc25 Phosphatase Inhibitors with Micromolar Activity Based on the Structure-Based Virtual Screening, Journal of Medicinal Chemistry, vol.51, issue.18, pp.5533-5541, 2008. ,
DOI : 10.1021/jm701157g
Induction of thioredoxin reductase as an adaptive response to acrolein in human umbilical vein endothelial cells, Biochem Biophys Res Commun, vol.327, issue.4, pp.1058-1065, 2005. ,
ROS stress in cancer cells and therapeutic implications, Drug Resistance Updates, vol.7, issue.2, pp.97-110, 2004. ,
DOI : 10.1016/j.drup.2004.01.004
Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A, Nature Cell Biology, vol.7, issue.4, pp.400-406, 2010. ,
DOI : 10.1038/ncb2041
Thioredoxin signaling as a target for cancer therapy, Current Opinion in Pharmacology, vol.7, issue.4, pp.392-397, 2007. ,
DOI : 10.1016/j.coph.2007.04.003
Noble metal targeting of thioredoxin reductase ??? covalent complexes with thioredoxin and thioredoxin-related protein of 14kDa triggered by cisplatin, Free Radical Biology and Medicine, vol.49, issue.11, pp.1765-1778, 2010. ,
DOI : 10.1016/j.freeradbiomed.2010.09.008
Substrate and inhibitor specificities differ between human cytosolic and mitochondrial thioredoxin reductases: Implications for development of specific inhibitors, Free Radic Biol Med, vol.50, issue.6, pp.689-699, 2011. ,
Increased expression of thioredoxin-1 in human colorectal cancer is associated with decreased patient survival, Journal of Laboratory and Clinical Medicine, vol.142, issue.1, pp.46-51, 2003. ,
DOI : 10.1016/S0022-2143(03)00068-4
The causes of cancer revisited: ???Mitochondrial malignancy??? and ROS-induced oncogenic transformation ??? Why mitochondria are targets for cancer therapy, Molecular Aspects of Medicine, vol.31, issue.2, pp.145-170, 2010. ,
DOI : 10.1016/j.mam.2010.02.008
A randomized phase II study of PX-12, an inhibitor of thioredoxin in patients with advanced cancer of the pancreas following progression after a gemcitabine-containing combination, Cancer Chemother Pharmacol, 2010. ,
A Phase I Pharmacokinetic and Pharmacodynamic Study of PX-12, a Novel Inhibitor of Thioredoxin-1, in Patients with Advanced Solid Tumors, Clinical Cancer Research, vol.13, issue.7, pp.2109-2114, 2007. ,
DOI : 10.1158/1078-0432.CCR-06-2250
CDC25A Phosphatase: a Rate-Limiting Oncogene That Determines Genomic Stability, Cancer Research, vol.68, issue.5, pp.1251-1253, 2008. ,
DOI : 10.1158/0008-5472.CAN-07-5983
Deregulated CDC25A expression promotes mammary tumorigenesis with genomic instability, Cancer Res, vol.67, issue.3, pp.984-991, 2007. ,
Lipid peroxidation, free radical production and antioxidant status in breast cancer, Breast Cancer Research and Treatment, vol.51, issue.3, pp.163-170, 2000. ,
DOI : 10.1016/0047-6374(90)90078-T
Development, The Plant Cell, vol.19, issue.6, pp.1851-1865, 2007. ,
DOI : 10.1105/tpc.107.050849
URL : https://hal.archives-ouvertes.fr/hal-01579585
Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2, Current Opinion in Cell Biology, vol.21, issue.2, pp.245-255, 2009. ,
DOI : 10.1016/j.ceb.2009.01.018
CELL SIGNALING: H2O2, a Necessary Evil for Cell Signaling, Science, vol.312, issue.5782, pp.1882-1883, 2006. ,
DOI : 10.1126/science.1130481
Peroxiredoxins: A historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling, Free Radical Biology and Medicine, vol.38, issue.12, pp.1543-1552, 2005. ,
DOI : 10.1016/j.freeradbiomed.2005.02.026
Sulfiredoxin, the cysteine sulfinic acid reductase specific to 2-Cys peroxiredoxin: its discovery, mechanism of action, and biological significance, Kidney International, vol.72, issue.106, pp.3-8, 2007. ,
DOI : 10.1038/sj.ki.5002380
Intracellular messenger function of hydrogen peroxide and its regulation by peroxiredoxins, Current Opinion in Cell Biology, vol.17, issue.2, pp.183-189, 2005. ,
DOI : 10.1016/j.ceb.2005.02.004
Controlled elimination of intracellular H(2)O(2): regulation of peroxiredoxin, catalase, and glutathione peroxidase via posttranslational modification, Antioxid Redox Signal, vol.7, pp.5-6, 2005. ,
Tumor Suppressive Effects of MnSOD Overexpression May Involve Imbalance in Peroxide Generation Versus Peroxide Removal, Antioxidants & Redox Signaling, vol.6, issue.3, pp.501-512, 2004. ,
DOI : 10.1089/152308604773934260
Effect of Auranofin on the mitochondrial generation of hydrogen peroxide. Role of thioredoxin reductase, Free Radical Research, vol.22, issue.7, pp.687-695, 2005. ,
DOI : 10.1074/jbc.M202026200
Gold(I) complexes determine apoptosis with limited oxidative stress in Jurkat T cells, European Journal of Pharmacology, vol.582, issue.1-3, pp.1-3, 2008. ,
DOI : 10.1016/j.ejphar.2007.12.026
Treatment of human cancer cells with selenite or tellurite in combination with auranofin enhances cell death due to redox shift, Free Radical Biology and Medicine, vol.47, issue.6, pp.710-721, 2009. ,
DOI : 10.1016/j.freeradbiomed.2009.05.027
Induction of mitochondrial permeability transition by auranofin, a Gold(I)-phosphine derivative, British Journal of Pharmacology, vol.1241, issue.Suppl., pp.1162-1168, 2002. ,
DOI : 10.1016/0304-4157(95)00003-A
Mitochondrial thioredoxin reductase inhibition by gold(I) compounds and concurrent stimulation of permeability transition and release of cytochrome c, Biochemical Pharmacology, vol.67, issue.4, pp.689-696, 2004. ,
DOI : 10.1016/j.bcp.2003.09.038
Gold(III) Dithiocarbamate Derivatives for the Treatment of Cancer:?? Solution Chemistry, DNA Binding, and Hemolytic Properties, Journal of Medicinal Chemistry, vol.49, issue.5, pp.1648-1657, 2006. ,
DOI : 10.1021/jm0509288
Estimation of cell survival by flow cytometric quantification of fluorescein diacetate/propidium iodide viable cell number, Cancer Res, vol.49, issue.14, pp.3776-3782, 1989. ,
Redox Regulation of the Cdc25 Phosphatases, Antioxidants & Redox Signaling, vol.7, issue.5-6, pp.761-767, 2005. ,
DOI : 10.1089/ars.2005.7.761
Mechanisms of Cell Death in Oxidative Stress, Antioxidants & Redox Signaling, vol.9, issue.1, pp.49-89, 2007. ,
DOI : 10.1089/ars.2007.9.49
Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1, The EMBO Journal, vol.17, issue.9, pp.2596-2606, 1998. ,
DOI : 10.1093/emboj/17.9.2596
Functions and Mechanisms of Redox Regulation of Cysteine-Based Phosphatases, Antioxidants & Redox Signaling, vol.7, issue.5-6, pp.5-6, 2005. ,
DOI : 10.1089/ars.2005.7.560
New insights into cyclins, CDKs, and cell cycle control, Seminars in Cell & Developmental Biology, vol.16, issue.3, pp.311-321, 2005. ,
DOI : 10.1016/j.semcdb.2005.02.007
Three-dimensional structure of a mammalian thioredoxin reductase: Implications for mechanism and evolution of a selenocysteine-dependent enzyme, Proceedings of the National Academy of Sciences, vol.332, issue.5482, pp.98-9533, 2001. ,
DOI : 10.1042/bj3320591
Antioxidant properties of dimethyl sulfoxide and its viability as a solvent in the evaluation of neuroprotective antioxidants, Journal of Pharmacological and Toxicological Methods, vol.63, issue.2, pp.209-215, 2011. ,
DOI : 10.1016/j.vascn.2010.10.004
Expression of the cdc25B mRNA Correlated with that of N-myc in Neuroblastoma, Japanese Journal of Clinical Oncology, vol.31, issue.9, pp.428-431, 2001. ,
DOI : 10.1093/jjco/hye093
Redox Regulation of Cdc25C, Journal of Biological Chemistry, vol.1176, issue.23, pp.20535-20540, 2002. ,
DOI : 10.1002/(SICI)1097-4652(199810)177:1<148::AID-JCP16>3.0.CO;2-9
Reactive oxygen species in cancer cells: Live by the sword, die by the sword, Cancer Cell, vol.10, issue.3, pp.175-176, 2006. ,
DOI : 10.1016/j.ccr.2006.08.015
Inhibition of Thioredoxin reductase induces apoptosis in neuronal cell lines: Role of glutathione and the MKK4/JNK pathway, Biochemical and Biophysical Research Communications, vol.359, issue.3, pp.759-764, 2007. ,
DOI : 10.1016/j.bbrc.2007.05.176
Thioredoxin expression in primary T-cell acute lymphoblastic leukemia and its therapeutic implication, Cancer Res, pp.61-7333, 2001. ,
A Human Cell Line From a Pleural Effusion Derived From a Breast Carcinoma
2, JNCI: Journal of the National Cancer Institute, vol.51, issue.5, pp.1409-1416, 1973. ,
DOI : 10.1093/jnci/51.5.1409
Acrolein: Sources, metabolism, and biomolecular interactions relevant to human health and disease, Molecular Nutrition & Food Research, vol.110, issue.4, pp.7-25, 2008. ,
DOI : 10.1289/ehp.02110s4505
Acrolein oxidizes the cytosolic and mitochondrial thioredoxins in human endothelial cells, Toxicology, vol.243, issue.1-2, pp.164-176, 2008. ,
DOI : 10.1016/j.tox.2007.10.004
Oxidative Stress in Breast Cancer, Medical Oncology, vol.22, issue.1, pp.11-15, 2005. ,
DOI : 10.1385/MO:22:1:011
/M Transition, Journal of Biological Chemistry, vol.19, issue.22, pp.16978-16990, 2010. ,
DOI : 10.1038/sj.emboj.7601136
Thioredoxin system inhibitors as mediators of apoptosis for cancer therapy, Molecular Nutrition & Food Research, vol.133, issue.235, pp.87-103, 2009. ,
DOI : 10.1016/S0360-3016(01)01810-7
Persistent oxidative stress in cancer, FEBS Letters, vol.54, issue.1, pp.1-3, 1995. ,
DOI : 10.1111/j.1432-1033.1991.tb16261.x
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?, Nature Reviews Drug Discovery, vol.104, issue.7, pp.579-591, 2009. ,
DOI : 10.4161/cbt.7.12.7067
Redox Regulation of Cell Survival, Antioxidants & Redox Signaling, vol.10, issue.8, pp.1343-1374, 2008. ,
DOI : 10.1089/ars.2007.1957
Oxidant Stress and B Vitamins Status in Patients With Non-Small Cell Lung Cancer, Nutrition and Cancer, vol.33, issue.1, pp.8-13, 2007. ,
DOI : 10.1016/S0955-2863(03)00009-3
Redox Control of Cell Death, Antioxidants & Redox Signaling, vol.4, issue.3, pp.405-414, 2002. ,
DOI : 10.1089/15230860260196209
Thioredoxin-dependent Redox Regulation of p53-mediated p21 Activation, Journal of Biological Chemistry, vol.72, issue.50, pp.35809-35815, 1999. ,
DOI : 10.1002/1097-0142(19920415)69:8<2091::AID-CNCR2820690814>3.0.CO;2-X
On the potential of thioredoxin reductase inhibitors for cancer therapy, Seminars in Cancer Biology, vol.16, issue.6, pp.452-465, 2006. ,
DOI : 10.1016/j.semcancer.2006.09.004
Free radicals and antioxidants in normal physiological functions and human disease, The International Journal of Biochemistry & Cell Biology, vol.39, issue.1, pp.44-84, 2007. ,
DOI : 10.1016/j.biocel.2006.07.001
Free radicals, metals and antioxidants in oxidative stress-induced cancer, Chemico-Biological Interactions, vol.160, issue.1, pp.1-40, 2006. ,
DOI : 10.1016/j.cbi.2005.12.009
Hydrogen Peroxide Sensing and Signaling, Molecular Cell, vol.26, issue.1, pp.1-14, 2007. ,
DOI : 10.1016/j.molcel.2007.03.016
Manganese superoxide dismutase overexpression inhibits the growth of androgen-independent prostate cancer cells, Oncogene, vol.24, issue.1, pp.77-89, 2005. ,
DOI : 10.1074/jbc.275.18.13175
Anticancer Therapeutics That Target Selenoenzymes: Synthesis, Characterization, in??????vitro Cytotoxicity, and Thioredoxin Reductase Inhibition of a Series of Gold(I) Complexes Containing Hydrophilic Phosphine Ligands, ChemMedChem, vol.193, issue.1, pp.96-102, 2010. ,
DOI : 10.1042/bj3320591
The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer, Cell Proliferation, vol.59, issue.3, pp.131-149, 2003. ,
DOI : 10.1101/gad.827700
M??canismes mol??culaires contr??lant le cycle cellulaire??: aspects fondamentaux et implications en canc??rologie, Cancer/Radioth??rapie, vol.5, issue.2, pp.109-129, 2001. ,
DOI : 10.1016/S1278-3218(01)00087-7
A Sugar-Modified Phosphole Gold Complex with Antiproliferative Properties Acting as a Thioredoxin Reductase Inhibitor in MCF-7 Cells, ChemMedChem, vol.40, issue.11, pp.1667-1670, 2008. ,
DOI : 10.1002/cmdc.200800210
Antitumor imidazolyl disulfide IV-2 causes irreversible G(2)/M cell cycle arrest without hyperphosphorylation of cyclin-dependent kinase Cdk1, J Pharmacol Exp Ther, vol.294, issue.3, pp.1070-1075, 2000. ,
DNA damage induced by endogenous aldehydes: Current state of knowledge, Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, vol.711, issue.1-2, pp.13-27, 2011. ,
DOI : 10.1016/j.mrfmmm.2011.03.006
Cellular processing of platinum anticancer drugs, Nature Reviews Drug Discovery, vol.11, issue.4, pp.307-320, 2005. ,
DOI : 10.1016/0006-2952(88)90325-5
Acrolein, an Environmental Toxin, Induces Cardiomyocyte Apoptosis via Elevated Intracellular Calcium and Free Radicals, Cell Biochemistry and Biophysics, vol.181, issue.1, 2011. ,
DOI : 10.1016/j.cbi.2009.07.001
Overexpression of CDC25B, CDC25C and phospho-CDC25C (Ser216) in vulvar squamous cell carcinomas are associated with malignant features and aggressive cancer phenotypes, BMC Cancer, vol.5, issue.1, p.233, 2010. ,
DOI : 10.1038/ncb994
Thioredoxin reductase-1 knock down does not result in thioredoxin-1 oxidation, Biochemical and Biophysical Research Communications, vol.368, issue.3, pp.832-836, 2008. ,
DOI : 10.1016/j.bbrc.2008.02.006
The redox protein thioredoxin-1, 2002. ,
Thiol chemistry and specificity in redox signaling, Free Radical Biology and Medicine, vol.45, issue.5, pp.549-561, 2008. ,
DOI : 10.1016/j.freeradbiomed.2008.05.004
Inhibition of thioredoxin reductase but not of glutathione reductase by the major classes of alkylating and platinum-containing anticancer compounds, Free Radical Biology and Medicine, vol.39, issue.5, pp.696-703, 2005. ,
DOI : 10.1016/j.freeradbiomed.2005.04.025
Redox-Directed Cancer Therapeutics: Molecular Mechanisms and Opportunities, Antioxidants & Redox Signaling, vol.11, issue.12, pp.3013-3069, 2009. ,
DOI : 10.1089/ars.2009.2541
URL : http://europepmc.org/articles/pmc2824519?pdf=render
Inactivation of Peroxiredoxin I by Phosphorylation Allows Localized H2O2 Accumulation for Cell Signaling, Cell, vol.140, issue.4, pp.517-528, 2010. ,
DOI : 10.1016/j.cell.2010.01.009
Upregulation of endothelial heme oxygenase-1 expression through the activation of the JNK pathway by sublethal concentrations of acrolein, Toxicology and Applied Pharmacology, vol.214, issue.3, pp.244-252, 2006. ,
DOI : 10.1016/j.taap.2005.12.013
Overexpression of cdc25A and cdc25B is frequent in primary non-small cell lung cancer but is not associated with overexpression of c-myc, Cancer Res, vol.58, issue.18, pp.4082-4085, 1998. ,
Expression of CDC25 Phosphatases in Human Gastric Cancer, Digestive Diseases and Sciences, vol.30, issue.Suppl 3, pp.949-953, 2008. ,
DOI : 10.3346/jkms.1999.14.5.526
Increased expression of thioredoxin/adult T-cell leukemia-derived factor in cisplatin-resistant human cancer cell lines, Clin Cancer Res, vol.2, issue.2, pp.427-432, 1996. ,
Overexpression of thioredoxin does not confer resistance to cisplatin in transfected human ovarian and colon cancer cell lines, Cancer Chemotherapy and Pharmacology, vol.40, issue.1, pp.31-37, 1997. ,
DOI : 10.1007/s002800050621
Effect of acrolein and glutathione depleting agents on thioredoxin, Toxicology, vol.204, issue.2-3, pp.209-218, 2004. ,
DOI : 10.1016/j.tox.2004.06.056
Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide, Cancer Res, vol.55, pp.4293-4296, 1995. ,
Redox Regulation of PTEN by S-nitrosothiols, Molecular Pharmacology, vol.68, issue.3, pp.847-854, 2005. ,
DOI : 10.1124/mol.104.010504
Oxidative stress-induced expression and modulation of Phosphatase of Regenerating Liver-1 (PRL-1) in mammalian retina, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol.1773, issue.9, pp.1473-1482, 2007. ,
DOI : 10.1016/j.bbamcr.2007.06.005